Steve Basta currently serves as CEO of Menlo Therapeutics, a dermatology drug development company. From 2002 through 2011, Steve served as CEO of BioForm Medical, Inc. and its successor, Merz Aesthetics, Inc. Under Steve’s leadership, BioForm became the third worldwide dermal filler company, and subsequent to the acquisition, Merz Aesthetics became the third worldwide minimally invasive aesthetics company with direct operations in 16 countries. Mr Basta’s previous experience includes President and CEO of Gliatech, Inc., a medical device company, VP Business Development and Chief Financial Officer of Creative BioMolecules, Inc., a protein therapy and drug device combination products company, and Executive Director of Product Development for The Immune Response Corporation, a biotechnology company. Steve also spent two years as an associate with the investment banking firm, Dillon, Read & Co. Inc.
Steve received his Master of Management degree from the Kellogg Graduate School of Business at Northwestern University, and his Bachelor’s degree in Biomedical Engineering from The Johns Hopkins University.
